Roumell Asset Management, LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 37 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Roumell Asset Management, LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,372,000
-57.9%
340,323
-54.9%
3.14%
-59.2%
Q3 2019$3,257,000
+20.3%
753,882
+11.1%
7.69%
+20.0%
Q2 2019$2,708,000
-23.2%
678,795
+3.2%
6.41%
-25.2%
Q1 2019$3,525,000
+52.5%
657,696
+46.0%
8.58%
+79.6%
Q4 2018$2,311,000
-5.4%
450,406
+78.9%
4.78%
+6.6%
Q3 2018$2,442,000
-7.0%
251,766
-2.2%
4.48%
-23.4%
Q2 2018$2,627,000
+2.4%
257,530
+30.5%
5.85%
+3.5%
Q1 2018$2,566,000
+42.4%
197,347
+96.0%
5.65%
+46.3%
Q4 2017$1,802,000
-29.2%
100,679
-0.7%
3.86%
-35.5%
Q3 2017$2,545,000
-59.0%
101,399
-60.7%
5.99%
-56.3%
Q2 2017$6,214,000
+32.3%
257,748
+5.6%
13.71%
+6.8%
Q1 2017$4,697,000
-2.4%
243,983
-21.9%
12.84%
+7.4%
Q4 2016$4,812,000
+29.9%
312,475
+9.7%
11.96%
+5.6%
Q3 2016$3,705,000
-8.2%
284,811
-1.8%
11.32%
+23.5%
Q2 2016$4,036,000
+22.5%
290,136
+33.6%
9.16%
+9.7%
Q1 2016$3,294,000
-13.0%
217,128
+8.8%
8.36%
-4.7%
Q4 2015$3,786,000
-1.3%
199,555
-1.1%
8.77%
+12.7%
Q3 2015$3,835,000
-28.4%
201,845
-2.8%
7.78%
-17.5%
Q2 2015$5,353,000
-19.4%
207,703
-2.2%
9.43%
-11.7%
Q1 2015$6,641,000
-25.6%
212,438
-8.2%
10.68%
-5.3%
Q4 2014$8,923,000231,47811.28%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders